Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | TACR2 | P21452 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1782962 | 1.00 | ALDH1A1 (0.51) | ALDH1A1HSD17B10HPGDCA2CA1 | |
| SCHEMBL1781155 | 0.89 | LPL (0.41) | ALDH1A1HSD17B10HPGDCA2THRB | |
| SCHEMBL1782120 | 0.82 | SMN1; SMN2 (0.39) | ALDH1A1HPGDKDM4ELMNATP53 | |
| SCHEMBL1782119 | 0.82 | SMN1; SMN2 (0.39) | ALDH1A1HPGDKDM4ELMNATP53 | |
| SCHEMBL1782936 | 0.78 | CTBP2 (0.38) | ALDH1A1HPGDEGFR | |
| SCHEMBL1782938 | 0.78 | CTBP2 (0.38) | ALDH1A1HPGDEGFR | |
| SCHEMBL2687223 | 0.76 | CES2 (0.41) | ALDH1A1CYP3A4KDM4ELMNACYP2C9 | |
| SCHEMBL1783394 | 0.74 | LMNA (0.43) | ALDH1A1HSD17B10CA2CA1LMNA | |
| SCHEMBL1785083 | 0.74 | CXCR1 (0.41) | ESR1LMNAADRB3CHRM1PTGS1 | |
| SCHEMBL1783392 | 0.74 | LMNA (0.43) | ALDH1A1HSD17B10CA2CA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168834-B2 | 4-alkyl 1-(3-methoxy-2-propen-1-yl) benzene compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-8168834-B2 | 4-alkyl 1-(3-methoxy-2-propen-1-yl) benzene compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | TRPA1, OR51E2, CYP1B1 | ALDH1A1 186/4885HSD17B10 1623/4885HPGD 1089/4885 |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | TRPA1, OR51E2, CYP1B1 | ALDH1A1 186/4885HSD17B10 1623/4885HPGD 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.